Trader consensus implies a 61.5% probability that the CDC will issue a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips due to high outbreak risk—by December 31, 2026, driven by the recent hantavirus cluster on M/V Hondius cruise ship, where 8 suspected cases and 3 deaths prompted CDC Emergency Operations Center activation at its lowest Level 3 routine response as of May 8. While no Level 3 notices exist currently per official CDC listings, and hantavirus transmission remains rodent-limited with low public risk, this development alongside ongoing Level 2 alerts for meningococcal disease in DRC, yellow fever in Venezuela, and chikungunya outbreaks has boosted sentiment. Weekly CDC FluView and surveillance updates could clarify escalation risks through year-end.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoCDC issues Level 3 warning by December 31?
CDC issues Level 3 warning by December 31?
$117,028 Wol.
$117,028 Wol.
Dec 31, 2026
$117,028 Wol.
$117,028 Wol.
Dec 31, 2026
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus implies a 61.5% probability that the CDC will issue a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips due to high outbreak risk—by December 31, 2026, driven by the recent hantavirus cluster on M/V Hondius cruise ship, where 8 suspected cases and 3 deaths prompted CDC Emergency Operations Center activation at its lowest Level 3 routine response as of May 8. While no Level 3 notices exist currently per official CDC listings, and hantavirus transmission remains rodent-limited with low public risk, this development alongside ongoing Level 2 alerts for meningococcal disease in DRC, yellow fever in Venezuela, and chikungunya outbreaks has boosted sentiment. Weekly CDC FluView and surveillance updates could clarify escalation risks through year-end.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Rynek otwarty: Jan 19, 2026, 3:15 PM ET
Wolumen
$117,028Data zakończenia
Dec 31, 2026Rynek otwarty
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus implies a 61.5% probability that the CDC will issue a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips due to high outbreak risk—by December 31, 2026, driven by the recent hantavirus cluster on M/V Hondius cruise ship, where 8 suspected cases and 3 deaths prompted CDC Emergency Operations Center activation at its lowest Level 3 routine response as of May 8. While no Level 3 notices exist currently per official CDC listings, and hantavirus transmission remains rodent-limited with low public risk, this development alongside ongoing Level 2 alerts for meningococcal disease in DRC, yellow fever in Venezuela, and chikungunya outbreaks has boosted sentiment. Weekly CDC FluView and surveillance updates could clarify escalation risks through year-end.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Wolumen
$117,028Data zakończenia
Dec 31, 2026Rynek otwarty
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus implies a 61.5% probability that the CDC will issue a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips due to high outbreak risk—by December 31, 2026, driven by the recent hantavirus cluster on M/V Hondius cruise ship, where 8 suspected cases and 3 deaths prompted CDC Emergency Operations Center activation at its lowest Level 3 routine response as of May 8. While no Level 3 notices exist currently per official CDC listings, and hantavirus transmission remains rodent-limited with low public risk, this development alongside ongoing Level 2 alerts for meningococcal disease in DRC, yellow fever in Venezuela, and chikungunya outbreaks has boosted sentiment. Weekly CDC FluView and surveillance updates could clarify escalation risks through year-end.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania